Sign In | Create an Account | Welcome, . My Account | Logout | Subscribe | Submit News | Contact Us | All Access E-Edition | Home RSS
 
 
 

Genentech Alzheimer’s drug misses goals in studies

July 17, 2014
By MARILYNN MARCHIONE , THE ASSOCIATED PRESS

An experimental drug from the biotech company Genentech failed to slow mental decline in mid-stage studies on more than 500 people with mild to moderate Alzheimer's disease, but showed some promise in the least-impaired participants who received a higher dose.

 
 
 

 

I am looking for: